| Elaine Victoria Selos-hoy, PA-C | |
|
5700 Cooper Foster Park Rd W, Lorain, OH 44053-4152 | |
| (440) 204-7439 | |
| Not Available |
| Full Name | Elaine Victoria Selos-hoy |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Experience | 22 Years |
| Location | 5700 Cooper Foster Park Rd W, Lorain, Ohio |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326018177 | NPI | - | NPPES |
| 000000331783 | Other | OH | ANTHEM |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363A00000X | Physician Assistant | 50-001953 (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Cleveland Clinic Avon Hospital | Avon, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cleveland Clinic Foundation | 1850203555 | 5690 |
News Archive
Researchers at the National Institutes of Health have identified a compound that prevents overproduction of thyroid hormone, a finding that brings scientists one step closer to improving treatment for Graves' disease.
For those 65 and older, falling can be fatal; in fact, the Centers for Disease Control and Prevention (CDC) reports that falls are the leading cause of injury-related deaths among this age group, and some 40 percent of seniors fall at least once each year. Additionally, one in four who sustains a hip fracture from a fall will die within a year, and another 50 percent will never return to their pre-fall level of mobility.
In a development that could pave the way for treatment for rare neurological diseases and clues to more common ones, physician-scientists at Albert Einstein College of Medicine of Yeshiva University and Montefiore Medical Center, the University Hospital for Einstein, have secured a grant to establish a clinical site for the Network for Excellence in Neuroscience Clinical Trials.
Perrigo Company today announced that it has received final approval from the U.S. Food and Drug Administration for its abbreviated new drug application (ANDA) for Desloratadine tablets.
Covidien, a leading global provider of healthcare products, and Nuvo Research Inc., a Canadian drug development company, today announced that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application for Pennsaid(R) Topical Solution (diclofenac sodium topical solution) 1.5% w/w.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Elaine Victoria Selos-hoy, PA-C 5700 Cooper Foster Park Road Ln20, Lorain, OH 44053 Ph: (440) 204-7439 | Elaine Victoria Selos-hoy, PA-C 5700 Cooper Foster Park Rd W, Lorain, OH 44053-4152 Ph: (440) 204-7439 |
News Archive
Researchers at the National Institutes of Health have identified a compound that prevents overproduction of thyroid hormone, a finding that brings scientists one step closer to improving treatment for Graves' disease.
For those 65 and older, falling can be fatal; in fact, the Centers for Disease Control and Prevention (CDC) reports that falls are the leading cause of injury-related deaths among this age group, and some 40 percent of seniors fall at least once each year. Additionally, one in four who sustains a hip fracture from a fall will die within a year, and another 50 percent will never return to their pre-fall level of mobility.
In a development that could pave the way for treatment for rare neurological diseases and clues to more common ones, physician-scientists at Albert Einstein College of Medicine of Yeshiva University and Montefiore Medical Center, the University Hospital for Einstein, have secured a grant to establish a clinical site for the Network for Excellence in Neuroscience Clinical Trials.
Perrigo Company today announced that it has received final approval from the U.S. Food and Drug Administration for its abbreviated new drug application (ANDA) for Desloratadine tablets.
Covidien, a leading global provider of healthcare products, and Nuvo Research Inc., a Canadian drug development company, today announced that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application for Pennsaid(R) Topical Solution (diclofenac sodium topical solution) 1.5% w/w.
› Verified 6 days ago
Caitlin Lee Crowell, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 3600 Kolbe Rd Ste 205, Lorain, OH 44053 Phone: 440-989-1800 Fax: 440-989-1801 | |
Mr. David M Iliano, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 3700 Kolbe Rd, Lorain, OH 44053 Phone: 440-960-4624 Fax: 440-960-4469 | |
Courtney Pearl Adelman, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 3700 Kolbe Rd, Lorain, OH 44053 Phone: 440-960-4000 | |
Alexandra Lynn Lucak, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 5800 Cooper Foster Park Rd W, Lorain, OH 44053 Phone: 440-204-7800 Fax: 440-204-7480 | |
Kimberly Telmanik, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 5172 Leavitt Rd, Lorain, OH 44053 Phone: 440-282-7420 Fax: 440-282-9855 | |
Bhavmik Patel, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 3600 Kolbe Rd Ste 106, Lorain, OH 44053 Phone: 440-960-3954 Fax: 440-960-3956 | |
Rachel Pidala, Physician Assistant Medicare: Medicare Enrolled Practice Location: 3700 Kolbe Rd Ste 120, Lorain, OH 44053 Phone: 440-960-4000 |